Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-11-18 Purchase |
2021-11-22 4:35 pm |
KIORA PHARMACEUTICALS INC | KPRX | Strem Brian M. President and CEO |
17,853 | $1.41 | $25,173 | 27,370 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-03-03 Option Award |
2023-03-07 8:15 pm |
N/A N/A |
KIORA PHARMACEUTICALS INC | KPRX | Strem Brian M. President and CEO |
15,600 | $3.83 | 39,183 (Direct) |
View |
| 2023-03-03 Option Award |
2023-03-07 8:15 pm |
N/A 2033-03-03 |
KIORA PHARMACEUTICALS INC | KPRX | Strem Brian M. President and CEO |
10,400 | $0 | 39,183 (Direct) |
View |
| 2023-03-03 Option Award |
2023-03-07 8:14 pm |
N/A 2033-03-03 |
KIORA PHARMACEUTICALS INC | KPRX | Daniels Eric Joseph Chief Development Officer |
26,000 | $0 | 36,238 (Direct) |
View |
| 2023-03-03 Option Award |
2023-03-07 8:14 pm |
N/A 2033-03-03 |
KIORA PHARMACEUTICALS INC | KPRX | Gayron Kenneth L Director |
8,000 | $0 | 8,000 (Direct) |
View |
| 2023-03-03 Option Award |
2023-03-07 8:14 pm |
N/A 2033-03-03 |
KIORA PHARMACEUTICALS INC | KPRX | Shapiro Aron Director |
8,000 | $0 | 8,000 (Direct) |
View |
| 2023-03-03 Option Award |
2023-03-07 8:14 pm |
N/A 2033-03-03 |
KIORA PHARMACEUTICALS INC | KPRX | TYLE PRAVEEN Director |
8,000 | $0 | 8,000 (Direct) |
View |
| 2023-03-03 Option Award |
2023-03-07 8:13 pm |
N/A 2033-03-03 |
KIORA PHARMACEUTICALS INC | KPRX | Hollander David Director |
8,000 | $0 | 8,000 (Direct) |
View |
| 2023-03-03 Option Award |
2023-03-07 8:13 pm |
N/A 2033-03-03 |
KIORA PHARMACEUTICALS INC | KPRX | CHANEY PAUL G Director |
8,000 | $0 | 8,000 (Direct) |
View |
| 2022-10-21 Option Award |
2022-10-25 5:34 pm |
N/A 2032-10-21 |
KIORA PHARMACEUTICALS INC | KPRX | Daniels Eric Joseph Chief Development Officer |
25,000 | $0 | 25,238 (Direct) |
View |
| 2022-10-21 Option Award |
2022-10-25 5:32 pm |
N/A 2032-10-21 |
KIORA PHARMACEUTICALS INC | KPRX | Tosca Melissa EVP of Finance |
7,500 | $0 | 7,500 (Direct) |
View |
| 2022-10-21 Option Award |
2022-10-25 5:30 pm |
N/A 2032-10-21 |
KIORA PHARMACEUTICALS INC | KPRX | Strem Brian M. President and CEO |
31,250 | $0 | 31,933 (Direct) |
View |
| 2022-02-10 Tax Withholding |
2022-02-11 4:31 pm |
N/A N/A |
KIORA PHARMACEUTICALS INC | KPRX | Romano Sarah Chief Financial Officer |
108 | $0.69 | 22,746 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 7:06 pm |
N/A 2032-02-01 |
KIORA PHARMACEUTICALS INC | KPRX | Romano Sarah Chief Financial Officer |
50,000 | $0 | 50,000 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 7:06 pm |
N/A 2032-02-01 |
KIORA PHARMACEUTICALS INC | KPRX | TYLE PRAVEEN Director |
5,000 | $0 | 5,000 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 7:05 pm |
N/A 2032-02-01 |
KIORA PHARMACEUTICALS INC | KPRX | CHANEY PAUL G Director |
5,000 | $0 | 5,000 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 7:04 pm |
N/A 2032-02-01 |
KIORA PHARMACEUTICALS INC | KPRX | Gayron Kenneth L Director |
5,000 | $0 | 5,000 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 7:04 pm |
N/A 2032-02-01 |
KIORA PHARMACEUTICALS INC | KPRX | Parsons Erin Director |
9,000 | $0 | 9,000 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 7:03 pm |
N/A 2032-02-01 |
KIORA PHARMACEUTICALS INC | KPRX | Daniels Eric Joseph Chief Development Officer |
25,000 | $0 | 25,000 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 7:02 pm |
N/A 2032-02-01 |
KIORA PHARMACEUTICALS INC | KPRX | Hollander David Director |
9,000 | $0 | 9,000 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 7:01 pm |
N/A 2032-02-01 |
KIORA PHARMACEUTICALS INC | KPRX | Strem Brian M. President and CEO |
75,000 | $0 | 75,000 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 7:01 pm |
N/A 2032-02-01 |
KIORA PHARMACEUTICALS INC | KPRX | Shapiro Aron Director |
5,000 | $0 | 5,000 (Direct) |
View |
| 2022-01-05 Tax Withholding |
2022-01-06 5:10 pm |
N/A N/A |
KIORA PHARMACEUTICALS INC | KPRX | Romano Sarah Chief Financial Officer |
114 | $1.08 | 22,854 (Direct) |
View |
| 2022-01-05 Tax Withholding |
2022-01-06 5:10 pm |
N/A N/A |
KIORA PHARMACEUTICALS INC | KPRX | FROM STEPHEN Executive Chairman |
326 | $1.08 | 67,693 (Direct) |
View |
| 2021-12-07 Tax Withholding |
2021-12-08 4:16 pm |
N/A N/A |
KIORA PHARMACEUTICALS INC | KPRX | FROM STEPHEN Executive Chairman |
273 | $1.3 | 68,019 (Direct) |
View |
| 2021-12-07 Tax Withholding |
2021-12-08 4:15 pm |
N/A N/A |
KIORA PHARMACEUTICALS INC | KPRX | Romano Sarah Chief Financial Officer |
91 | $1.3 | 22,968 (Direct) |
View |
| 2021-10-21 Option Award |
2021-11-22 4:35 pm |
N/A N/A |
KIORA PHARMACEUTICALS INC | KPRX | Strem Brian M. President and CEO |
9,517 | $0 | 27,370 (Direct) |
View |
| 2021-10-21 Option Award(A) |
2021-11-22 4:31 pm |
N/A N/A |
KIORA PHARMACEUTICALS INC | KPRX | Daniels Eric Joseph Chief Development Officer |
9,520 | $0 | 9,520 (Direct) |
View |
| 2021-10-21 Option Award |
2021-11-10 4:17 pm |
N/A 2031-10-21 |
KIORA PHARMACEUTICALS INC | KPRX | Daniels Eric Joseph Chief Development Officer |
50,000 | $0 | 50,000 (Direct) |
View |
| 2021-11-02 Tax Withholding |
2021-11-03 4:16 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | FROM STEPHEN Executive Chairman |
250 | $1.98 | 68,292 (Direct) |
View |
| 2021-11-02 Tax Withholding |
2021-11-03 4:16 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | Mann Brenda VP of Research & Development |
62 | $1.98 | 15,136 (Direct) |
View |
| 2021-11-02 Tax Withholding |
2021-11-03 4:15 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | Romano Sarah Chief Financial Officer |
83 | $1.98 | 23,059 (Direct) |
View |
| 2021-10-04 Tax Withholding |
2021-10-05 6:40 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | Romano Sarah Chief Financial Officer |
83 | $2.01 | 23,142 (Direct) |
View |
| 2021-10-04 Tax Withholding |
2021-10-05 6:40 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | Mann Brenda VP of Research & Development |
62 | $2.01 | 15,198 (Direct) |
View |
| 2021-10-04 Tax Withholding |
2021-10-05 6:39 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | FROM STEPHEN Executive Chairman |
249 | $2.01 | 68,542 (Direct) |
View |
| 2021-09-02 Tax Withholding |
2021-09-03 4:17 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | FROM STEPHEN Executive Chairman |
253 | $1.81 | 68,791 (Direct) |
View |
| 2021-09-02 Tax Withholding |
2021-09-03 4:16 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | Romano Sarah Chief Financial Officer |
84 | $1.81 | 23,225 (Direct) |
View |